2025-522297-36-00招募中1 期
Randomized, open-label, three-period crossover study on the palatability of oral dispersible formulations of Zonisamide in healthy volunteers.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 16
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Daniel Peris
Scientific
Noucor Health S.A.
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Relative bioavailability study of marketed and lower dose ambrisentan in healthy adult participantsPulmonary arterial hypertensionEUCTR2019-001699-12-GBGlaxoSmithKline Research and Development Ltd24
已完成
1 期
An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condition and a tablet under fasting and fed conditions in healthy volunteers.Non-small Cell Lung Cancer2022-502200-67-00Galecto Biotech AB12
已完成
不适用
An open*label, randomized, 3*period crossover study to determine the relative bioavailability of ASN120290 from a film*coated tablet given under fasted and fed conditions as compared to a capsule given under fasted conditions in healthy subjectsPSPNL-OMON48189Asceneuron SA15
尚未招募
不适用
An investigator initiated study to study how well does a newly developed spirometer by Cipla Ltd. work as compared to the spirometer already available in the market.CTRI/2019/08/020738Chest Research Foundation
已完成
不适用
A randomized, open-label, two-period, crossover study to determine the pharmacokinetics of reconstituted lyophilized Erelzi and Enbrel® (US-licensed) following a single subcutaneous injection in healthy male subjects.rheumatoid arthritisNL-OMON45782Hexal AG56